Expand GH Menu
GH MENU

GH Latest Press Releases

-- December 9, 2024 --

Guardant Health to Share New Research Demonstrating Value of Liquid Biopsy Tests, Real-world Data and AI Analytics in Tailoring Treatment Approaches for Breast Cancer at 2024 San Antonio Breast Cancer Symposium Business Wire 8:05 AM

-- November 25, 2024 --

Federal Court Jury Issues Unanimous Verdict that Natera Engaged in False Advertising and Unfair Competition in Deliberate Attempt to Damage Guardant Health's Colorectal Cancer Test, Guardant Reveal PRNewswire 5:09 PM

-- November 13, 2024 --

Guardant Health Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Business Wire 5:05 PM

-- November 6, 2024 --

Guardant Health Reports Third Quarter 2024 Financial Results and Increases 2024 Revenue Guidance Business Wire 4:05 PM

-- November 1, 2024 --

Guardant Health to Participate in Upcoming Investor Conferences Business Wire 7:00 AM

-- October 30, 2024 --

Guardant Health Named to TIME's List of the Best Inventions of 2024 Business Wire 9:30 AM

-- October 28, 2024 --

Guardant Health to Share Data Supporting Critical Role of Blood-Based Testing in Colorectal Cancer Screening at ACG 2024 Business Wire 8:05 AM

-- October 24, 2024 --

Roberto A. Mignone Joins Guardant Health Board of Directors Business Wire 5:05 PM

-- October 15, 2024 --

Guardant Health to Report Third Quarter 2024 Financial Results on November 6, 2024 Business Wire 4:05 PM

-- September 18, 2024 --

GOZILA Study Published in Nature Medicine Shows Patients With Advanced Cancer Who Receive Liquid Biopsy-Guided Treatment Using Guardant360 CDx Survive Twice as Long Business Wire 8:05 AM

-- September 13, 2024 --

Guardant Health to Share Data at ESMO 2024 Further Demonstrating Strong Performance of Its Precision Oncology Technology in Multiple Advanced Tumor Types Business Wire 2:00 AM

-- September 10, 2024 --

Guardant Health and Policlinico Gemelli Announce Partnership to Establish A Dedicated In-House Liquid Biopsy Testing Service in Italy Business Wire 8:00 AM

-- August 27, 2024 --

Guardant Health to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference Business Wire 4:05 PM

-- August 22, 2024 --

Guardant Health to Ring the Nasdaq Opening Bell on August 28 to Celebrate the Launch of Shield Blood Test for Colorectal Cancer Screening Business Wire 5:00 PM

-- August 8, 2024 --

Guardant Health to Participate in Upcoming Investor Conferences Business Wire 4:05 PM

-- August 7, 2024 --

Guardant Health Reports Second Quarter 2024 Financial Results and Increases 2024 Revenue Guidance Business Wire 4:05 PM
Guardant Health COSMOS Study Published in Clinical Cancer Research Validates Utility of Guardant Reveal Liquid Biopsy Test for Predicting Recurrence in Colorectal Cancer Business Wire 8:05 AM

-- August 1, 2024 --

Guardant Health's FDA-approved Shield Blood Test Now Commercially Available in U.S. as a Primary Screening Option for Colorectal Cancer Business Wire 8:30 AM
Guardant Health Outcomes Model Confirms the Public Health Importance of Enhanced Colorectal Cancer Screening Outcomes with High Adherence Strategies Business Wire 8:00 AM

-- July 29, 2024 --

Guardant Health's Shield Blood Test Approved by FDA as a Primary Screening Option, Clearing Path for Medicare Reimbursement and a New Era of Colorectal Cancer Screening Business Wire 6:30 AM

-- July 24, 2024 --

Guardant Health to Report Second Quarter 2024 Financial Results on August 7, 2024 Business Wire 4:05 PM

-- July 23, 2024 --

Guardant Health Introduces Major Smart Liquid Biopsy Upgrade to Market-Leading Guardant360 Test, Further Extending Its Best-in-Class Performance Business Wire 8:05 AM

-- July 18, 2024 --

Dr. Manuel Hidalgo Medina Joins Guardant Health Board of Directors Business Wire 5:00 PM